Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)2,198.00
  • Today's Change18.00 / 0.83%
  • Shares traded8.48m
  • 1 Year change48.56%
  • Beta0.7079
Data delayed at least 20 minutes, as of Feb 06 2026 14:54 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2025202520242023
OPERATIONS
Net income6,2892,9515,308
Depreciation/depletion3,7781,0971,082
Non-Cash items1,6431,5041,992
Cash taxes paid, supplemental1,2021,3071,328
Cash interest paid, supplemental679632766
Changes in working capital(3969)(452)(2826)
Total cash from operations7,7416,5546,768
INVESTING
Capital expenditures(2985)(2982)(2344)
Other investing and cash flow items, total(1248)1,753749
Total cash from investing(4233)(1229)(1595)
FINANCING
Financing cash flow items(1024)(910)(837)
Total cash dividends paid(2564)(2444)(2247)
Issuance (retirement) of stock, net(1362)2010.00
Issuance (retirement) of debt, net1,265(1392)(2567)
Total cash from financing(3685)(4726)(5641)
NET CHANGE IN CASH
Foreign exchange effects(19)(54)(99)
Net change in cash(196)545(567)
Net cash-begin balance/reserved for future use3,4032,8583,425
Net cash-end balance/reserved for future use3,2073,4032,858
SUPPLEMENTAL INCOME
Depreciation, supplemental3,7781,0971,082
Cash interest paid, supplemental679632766
Cash taxes paid, supplemental1,2021,3071,328
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.